CYNAPSUS
DEAD

Serial Number

87078707

Owner

SUNOVION PHARMACEUTICALS INC.

Attorney

Jeffrey R. Cadwell

Filing Date

Jun 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CYNAPSUS Trademark

Serial Number: 87078707

CYNAPSUS is a trademark filed by SUNOVION PHARMACEUTICALS INC. on June 21, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SUNOVION PHARMACEUTICALS INC. (260 trademarks)

Marlborough, MA 01752

Entity Type: 03

Cynapsus Therapeutics Inc. (4 trademarks)

828 Richmond Street West
Toronto, Ontario M6J1C9 , CA

Entity Type: 03

Trademark Details

Filing Date

June 21, 2016

Registration Date

Not Registered

Published for Opposition

October 6, 2020

Goods & Services

Sublingual thin filmstrip of apomorphine to treat Parkinson's Disease OFF hypomobility episodes; pharmaceutical preparations for the treatment of Parkinson's Disease OFF hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic preparations to manage Parkinson's Disease OFF hypomobility episodes, delivered orally via a sublingual thin filmstrip; pharmaceutical preparations for the treatment of Parkinson's Disease; therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease; pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system movement disorders and infections, and brain diseases; therapeutic pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system movement disorders and infections, and brain diseases; pharmaceutical preparations acting on the central nervous system; therapeutic pharmaceutical preparations acting on the central nervous system; drug delivery agents in the form of sublingual filmstrips to facilitate delivery of a wide range of prescription pharmaceuticals by providing release of active ingredients

Providing information regarding Parkinson's disease and Parkinson's disease OFF hypomobility episodes; providing information in the field of central nervous system disorders, infections, and diseases

Research and development of medicines and vaccines in the field of central nervous system pharmaceuticals; pharmaceutical research and development; research and development of medicines

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 2, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 1, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 13, 2023 EXRA
SOU EXTENSION 5 GRANTED
Apr 12, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 10, 2023 AITU
SOU EXTENSION 5 FILED
Apr 4, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 4, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2022 EXRA
SOU EXTENSION 4 GRANTED
Nov 21, 2022 EX4G
SOU EXTENSION 4 FILED
Nov 21, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 21, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 16, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 16, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 16, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 3, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jun 1, 2022 EX3G
SOU EXTENSION 3 FILED
Jun 1, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 26, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 26, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 26, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2021 EXRA
SOU EXTENSION 1 GRANTED
May 25, 2021 EX1G
SOU EXTENSION 1 FILED
May 25, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
May 25, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 7, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 7, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 7, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 7, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 7, 2021 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 6, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 12, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 21, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 21, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 21, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 31, 2020 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 11, 2019 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 16, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 16, 2018 GNSL
SUSPENSION LETTER WRITTEN
Dec 16, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 19, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 5, 2018 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 17, 2018 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 11, 2017 RCSC
ASSIGNED TO LIE
Oct 9, 2017 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 27, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 27, 2017 GNSL
SUSPENSION LETTER WRITTEN
Mar 27, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2017 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 11, 2017 ASCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2016 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 7, 2016 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2016 NWOS
NEW APPLICATION ENTERED
Jun 24, 2016 NWAP